Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma
Pancreatic cancer ranks among the tumors most resistant to chemotherapy. Such chemoresistance of tumors can be mediated by various cellular mechanisms including dysregulated apoptosis or ineffective drug concentration at the intracellular target sites. In this review, we highlight recent advances in...
Main Authors: | Ralf Jesnowski, Martina Schnölzer, Matthias Löhr, Wolfgang Hagmann, Ralf Faissner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/3/1/106/ |
Similar Items
-
Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
by: Raúl Muñoz Velasco, et al.
Published: (2022-03-01) -
Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01) -
Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
by: Annalisa Comandatore, et al.
Published: (2022-01-01) -
Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer
by: Manoj Amrutkar, et al.
Published: (2021-02-01) -
M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
by: Yongmei Zhao, et al.
Published: (2021-09-01)